Longevity Health Holdings, Inc. (XAGE): Nasdaq/NYSE listing notice — Alpha Healthcare Acquisition Corp. III receives Nasdaq deficiency notice for insufficient public holders

Longevity Health Holdings, Inc.

Received Nasdaq notice on March 29, 2023 for non-compliance with minimum 300 public holders rule (Listing Rule 5550(a)(3)).
Company has 45 calendar days to submit a plan to regain compliance with the Minimum Public Holders Rule.
If plan accepted, Nasdaq may grant up to 180-day extension from notice date to evidence compliance.
If plan not accepted, company can appeal the decision to a Nasdaq Hearings Panel.
Notice has no immediate effect on listing or trading of the Company's securities on Nasdaq Capital Market.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Longevity Health Holdings, Inc. received a nasdaq deficiency notice notice regarding other (rules 5550(a)(3)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5550(a)(3)

Exact text from the filing

March 29, 2023, Alpha Healthcare Acquisition Corp. III (the “ Company ”) received a written notice (the “ Notice ”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that the Company was not in compliance with Listing Rule 5550(a)(3), which requires the Company to have at least 300 public holders for continued listing on the Nasdaq Capital Market (the “ Minimum Public Holders Rule ”). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on Na

View on SEC.gov

Browse all listing & compliance notices →

Longevity Health Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-087992

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.